Incyte
NEWS
The action data was extended by the agency to provide more time to review new data analyses submitted by Lilly, per information requests made by the FDA.
The topline data from the BRAVE-AA2 study in 546 adults showed both 2 mg and 4 mg doses of Olumiant regrew hair in adult patients with more than 50% scalp hair loss, compared with placebo.
Many companies appear to be getting their clinical trial news updated ahead of the holidays. Here’s a look.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 15, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for November 24, 2020.
It was relatively quiet in terms of COVID-19-related clinical trials, but there was still quite a bit of news for trials involving other indications. Here’s a look.
It was a moderately busy week for clinical trial news. Here’s a look.
Biopharma companies focused on oncology continue to release data that will be presented at the 2020 virtual meeting of the European Society of Medical Oncology.
It was a fairly busy week for clinical trial announcements, with some important and interesting news about COVID-19 treatments and vaccines, as well as numerous stories about non-COVID-19 studies.
JOBS
IN THE PRESS